finance.yahoo.com

Abbott to Pay $670 Million to Settle Preterm Formula NEC Claims

Abbott Laboratories logoAbbott Laboratories
Sig4.35Sen-4.55Env0.00Soc-6.20Gov-4.10

Abbott Laboratories will pay $670 million to settle claims involving about 2,000 people who alleged its specialized preterm infant formulas contributed to necrotizing enterocolitis in premature infants. The deal also resolves Abbott’s appeal of a $495 million verdict upheld by a Missouri appeals court. Litigation continues, with more than 825 federal cases in Chicago. Separately, regulators and an NIH working group linked higher NEC rates to the absence of breast milk.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro